Completed OBSERVATIONAL NCT02715752

A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

Sponsor: The Center for the Biology of Chronic Disease

Conditions Cytomegalovirus Infections Epstein-Barr Virus Infections Herpes Simplex Infections Human Papillomavirus Varicella-zoster Virus Infection

Interventions Gene-Eden-VIR/Novirin

Updated 6 times since 2017 Last updated: Apr 24, 2016 Started: Jan 31, 2016 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02715752, this observational or N/A phase trial focuses on Cytomegalovirus Infections and Epstein-Barr Virus Infections and remains completed. Sponsored by The Center for the Biology of Chronic Disease, it has been updated 6 times since 2016, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Center for the Biology of Chronic Disease

Data source: The Center for the Biology of Chronic Disease

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valley Cottage, United States